发明名称 |
SELECTION OF HCV TREATMENT |
摘要 |
The present invention is based on the discovery of an association between the SNP genotype at the rs12979860 locus in the IL28B gene promoter and the probability of achieving a SVR in HC V-infected patients that are given a triple therapy treatment that contains peginterferon alfa-2a, ribavirin, and a HCV NS5B polymerase inhibitor. |
申请公布号 |
EP2694078(A1) |
申请公布日期 |
2014.02.12 |
申请号 |
EP20120712098 |
申请日期 |
2012.03.28 |
申请人 |
F.HOFFMANN-LA ROCHE AG |
发明人 |
IGLESIAS, VICTOR;IPE, DAVID;THOMMES, JAMES;ZHU, YONGHONG |
分类号 |
A61K31/7056;A61K31/7068;A61K38/21;A61K45/06;A61P31/14;C12Q1/68 |
主分类号 |
A61K31/7056 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|